Drugs & Targets Estonia to develop personalized CAR T-cell therapy for blood cancer patients May 31, 2024Vol.50 No.22
Drugs & Targets Secarna, Orbit collaborate to develop peptide-conjugated targeted ASO therapeutics May 31, 2024Vol.50 No.22
Drugs & Targets Cartography, Gilead collaborate to develop therapies for breast and lung cancers May 31, 2024Vol.50 No.22
Drugs & Targets FDA advisory committee recommends approval of Shield blood test for colorectal cancer screening May 24, 2024Vol.50 No.21
Drugs & Targets FDA withdraws accelerated approval of infigratinib for metastatic cholangiocarcinoma with FGFR2 May 24, 2024Vol.50 No.21
Drugs & Targets FDA forms OCE Equity Program to improve clinical trial access May 24, 2024Vol.50 No.21
Drugs & Targets FDA, EMA grant Orphan Drug Designation to Carthera for carboplatin with SonoCloud technology in glioma May 17, 2024Vol.50 No.20
Drugs & Targets Leal Health announces next-gen AI patient support platform to enable cancer treatment navigation May 17, 2024Vol.50 No.20
